TF and cancer: The combination of active targeting transferrin, with the passive accumulation of liposomes in tumours due to the enhanced permeability and retention effect (Maeda, 1992), should provide tumour‐selective targeting of the plumbagin‐loaded liposomes to the cancer cells (Zheng et al., 2010; Guo et al., 2015).